Erleada 60 mg
Erleada 60 mg is a medicine authorised by Swissmedic under authorisation number 67072. The authorisation holder is Janssen-Cilag AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 19 September 2019 and the authorisation is valid without a time limit. ATC code L02BB05 places the medicine in the group Endocrine therapy.
| Authorisation number | 67072 |
|---|---|
| Name | Erleada 60 mg |
| Full name | Erleada 60 mg, Filmtabletten |
| Authorisation holder | Janssen-Cilag AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | L02BB05 |
| First authorisation | 19 September 2019 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Erleada 60 mg, Filmtabletten | B | 19 September 2019 |
| 2 | Erleada 240 mg, Filmtabletten | B | 06 October 2023 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 4 x 28 | Tablette(n) | L02BB05 | 07.16.2. | B |
| 2 | 2 x 14 | Tablette(n) | L02BB05 | 07.16.2. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Erleada 60 mg authorised in Switzerland?
Yes. Erleada 60 mg is authorised by Swissmedic under authorisation number 67072, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Erleada 60 mg have?
Erleada 60 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Erleada 60 mg?
The authorisation holder is Janssen-Cilag AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.